10-Q Filing

RELMADA THERAPEUTICS, INC. CIK: 1553643 Q1 2017

Filing Information

Form Type	10-Q
Accession Number	`0001213900-16-018211`
Period End Date	20160930
Filing Date	20161110
Fiscal Year	2017
Fiscal Period	Q1
XBRL Instance	rlmd-20160930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 60 Income Statement 26 Cash Flow Statement 45

Balance Sheet 60 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$22.47M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$8.50M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$6.22M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$19.17M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Other receivable	`OtherReceivablesNetCurrent`	$2.35K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Other receivable	`OtherReceivablesNetCurrent`	-	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$798.09K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$747.52K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$6.97M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$9.30M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	12.04M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	12.04M	shares	Point-in-time
Fixed assets, net	`PropertyPlantAndEquipmentNet`	$531.35K	USD	Point-in-time
Fixed assets, net	`PropertyPlantAndEquipmentNet`	$536.01K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$414.62K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	12.04M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	12.04M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$414.36K	USD	Point-in-time
Total assets	`Assets`	$10.24M	USD	Point-in-time
Total assets	`Assets`	$7.92M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$671.72K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.26M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$634.85K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$404.89K	USD	Point-in-time
Note payable	`NotesPayableCurrent`	$273.67K	USD	Point-in-time
Note payable	`NotesPayableCurrent`	$164.44K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$892.50K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$972.55K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.06M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.21M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$140.91K	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$134.74K	USD	Point-in-time
Total liabilities	`Liabilities`	$2.35M	USD	Point-in-time
Total liabilities	`Liabilities`	$3.20M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, value	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, value	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value,100,000,000 shares authorized, 12,035,912 and 12,035,037 shares issued and outstanding, respectively	`CommonStockValue`	$12.04K	USD	Point-in-time
Common stock, $0.001 par value,100,000,000 shares authorized, 12,035,912 and 12,035,037 shares issued and outstanding, respectively	`CommonStockValue`	$12.04K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$86.30M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$86.13M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-80.74M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-79.10M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$5.57M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$7.04M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$7.92M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$10.24M	USD	Point-in-time

Income Statement 26 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$2.87M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$364.15K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.25M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.76M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$4.63M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.62M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-4.63M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-1.62M	USD	1 Quarter
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$9.29M	USD	1 Quarter
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$-80.04K	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNet`	$-851.00	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNet`	$-598.00	USD	1 Quarter
Other income	`OtherNonoperatingIncome`	$56.91K	USD	1 Quarter
Other income	`OtherNonoperatingIncome`	-	USD	1 Quarter
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$-23.98K	USD	1 Quarter
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$9.29M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-1.64M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$4.66M	USD	1 Quarter
Net (loss) income per common share - basic	`EarningsPerShareBasic`	$0.43	USD	1 Quarter
Net (loss) income per common share - basic	`EarningsPerShareBasic`	$-0.14	USD	1 Quarter
Net (loss) income per common share - diluted	`EarningsPerShareDiluted`	$-0.14	USD	1 Quarter
Net (loss) income per common share - diluted	`EarningsPerShareDiluted`	$0.36	USD	1 Quarter
Weighted average number of common stock outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	10.80M	shares	1 Quarter
Weighted average number of common stock outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	12.04M	shares	1 Quarter
Weighted average number of common stock outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.04M	shares	1 Quarter
Weighted average number of common stock outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.94M	shares	1 Quarter

Cash Flow Statement 45 line items

Line Item	Tag	Value	Unit	Period
Net (loss) income	`NetIncomeLoss`	$-1.64M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$4.66M	USD	1 Quarter
Depreciation expense	`Depreciation`	$20.16K	USD	1 Quarter
Depreciation expense	`Depreciation`	$2.95K	USD	1 Quarter
Common stock issued for services	`CommonStockIssuedForServices`	$78.92K	USD	1 Quarter
Common stock issued for services	`CommonStockIssuedForServices`	-	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$172.06K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$283.50K	USD	1 Quarter
Change in fair value of derivative liabilities	`IncreaseDecreaseInDerivativeLiabilities`	$80.04K	USD	1 Quarter
Change in fair value of derivative liabilities	`IncreaseDecreaseInDerivativeLiabilities`	$-9.29M	USD	1 Quarter
Other receivable	`IncreaseDecreaseInOtherReceivables`	$2.35K	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpensesOther`	$-601.93K	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpensesOther`	$-50.31K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-587.99K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$314.71K	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$132.26K	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-229.97K	USD	1 Quarter
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	-	USD	1 Quarter
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$-6.18K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.14M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.22M	USD	1 Quarter
Purchase of fixed assets	`PaymentsToAcquireProductiveAssets`	$24.83K	USD	1 Quarter
Purchase of fixed assets	`PaymentsToAcquireProductiveAssets`	$1.31K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-24.83K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.31K	USD	1 Quarter
Principal payments of note payable	`RepaymentsOfNotesPayable`	$87.30K	USD	1 Quarter
Principal payments of note payable	`RepaymentsOfNotesPayable`	$109.23K	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-109.23K	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-87.30K	USD	1 Quarter
Net decrease in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-2.28M	USD	1 Quarter
Net decrease in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-3.30M	USD	1 Quarter
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$22.47M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$8.50M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$6.22M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$19.17M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$22.47M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$8.50M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$6.22M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$19.17M	USD	Point-in-time
Interest	`InterestPaid`	$2.64K	USD	1 Quarter
Interest	`InterestPaid`	$1.64K	USD	1 Quarter
Income taxes	`IncomeTaxesPaid`	-	USD	1 Quarter
Income taxes	`IncomeTaxesPaid`	-	USD	1 Quarter
Conversion of Class A convertible preferred stock to common stock	`ConversionOfStockAmountConverted1`	$220.00	USD	1 Quarter
Conversion of Class A convertible preferred stock to common stock	`ConversionOfStockAmountConverted1`	-	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.